Literature DB >> 11826229

Xylitol administered only during respiratory infections failed to prevent acute otitis media.

Terhi Tapiainen1, Leevi Luotonen, Tero Kontiokari, Marjo Renko, Matti Uhari.   

Abstract

OBJECTIVE: As regular administration of xylitol had been effective in preventing acute otitis media (AOM) in children, we tested whether xylitol administered only at times of acute respiratory infection (ARI) reduces the occurrence of AOM.
METHODS: Healthy children (N = 1277) were recruited from child care centers and randomized after screening with tympanometry to receive either control mixture (n = 212), xylitol mixture (n = 212), control chewing gum (n = 280), xylitol chewing gum (n = 286), or xylitol lozenges (n = 287) during an ARI. The trial was randomized and double blinded within the mixture and chewing gum groups. The parents began administering the products to their children at the onset of symptoms of ARI. The follow-up lasted until resolution of the symptoms or up to 3 weeks.
RESULTS: A total of 1253 of the 1277 randomized children were eligible for the analysis. Altogether, 980 (78%) of 1253 children had at least 1 episode of ARI during the 4 months that the trial lasted. The occurrence of AOM during this episode was 34 (20.5%) of 166 in the xylitol mixture group, as compared with 32 (20.4%) of 157 among the children who received the control mixture. Among the older children who received control chewing gum, xylitol chewing gum, or xylitol lozenges, AOM was experienced by 24 (11.0%) of 218, 31 (14.1%) of 220, and 34 (15.5%) of 219, respectively. None of the differences between the groups was statistically significant.
CONCLUSIONS: Xylitol administered only during an ARI was ineffective in preventing AOM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826229     DOI: 10.1542/peds.109.2.e19

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Xylitol syrup for the prevention of acute otitis media.

Authors:  Louis Vernacchio; Michael J Corwin; Richard M Vezina; Steven I Pelton; Henry A Feldman; Tamera Coyne-Beasley; Allen A Mitchell
Journal:  Pediatrics       Date:  2014-01-06       Impact factor: 7.124

Review 2.  AOM in children.

Authors:  Roger A J M Damoiseaux; Maroeska M Rovers
Journal:  BMJ Clin Evid       Date:  2011-05-10

3.  Tolerability of oral xylitol solution in young children: implications for otitis media prophylaxis.

Authors:  Louis Vernacchio; Richard M Vezina; Allen A Mitchell
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-11-09       Impact factor: 1.675

Review 4.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Probiotic capsules and xylitol chewing gum to manage symptoms of pharyngitis: a randomized controlled factorial trial.

Authors:  Paul Little; Beth Stuart; Zoe Wingrove; Mark Mullee; Tammy Thomas; Sophie Johnson; Gerry Leydon; Samantha Richards-Hall; Ian Williamson; Lily Yao; Shihua Zhu; Michael Moore
Journal:  CMAJ       Date:  2017-12-18       Impact factor: 8.262

6.  Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.

Authors:  Suvi Sarlin; Mysore V Tejesvi; Jenni Turunen; Petri Vänni; Tytti Pokka; Marjo Renko; Terhi Tapiainen
Journal:  Pediatr Infect Dis J       Date:  2021-05-01       Impact factor: 2.129

Review 7.  Complementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic Review.

Authors:  Tal Marom; Paola Marchisio; Sharon Ovnat Tamir; Sara Torretta; Haim Gavriel; Susanna Esposito
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

Review 8.  The common cold.

Authors:  Terho Heikkinen; Asko Järvinen
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 9.  Prevention of otitis media caused by viral upper respiratory tract infection: vaccines, antivirals, and other approaches.

Authors:  William J Doyle; Cuneyt M Alper
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.